Atlas Trials

Safety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of HSV and HIV

Clinical trial NCT02579083 · COMPLETED

Trial details

NCT number
NCT02579083
Sponsor
KBio Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIVHerpes Simplex Infections
Start date
2016-01-01
Primary completion
2018-07-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.